Scientists are beginning to discover myriad strategies tumors use to avoid attacks by anti-cancer drugs.
The Scientist
Most Recent
A special glucose molecule makes tumor cells more vulnerable to a pair of cancer cell-killing drugs.
Why obese individual are more likely to get cancer could be partly explained by a gene that activates both pathways.
After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.
A new study suggests a possible link between the use of oral contraceptives and rising prostate cancer rates.
A genetically engineered smallpox vaccine improved the survival of liver cancer patients participating in a phase II clinical trial.
Researchers have developed a way to activate cancer fighting drugs by pulsing them with light, which could make such therapies safer.
An alternative form of an enzyme involved in the glucose metabolism pathway protects cancer cells from oxidative stress.
Researchers scan the molecules in spider venom for anti-cancer effects in tissue culture.
Researchers diagnose the second oldest known case of prostate cancer in a two-thousand-year-old-Egyptian mummy.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
